Author Remke, Marc

1 to 4 of 4 Items
  • 2013 | Journal Article
    ​ ​Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma​
    Zhukova, N.; Ramaswamy, V.; Remke, M.; Pfaff, E.; Shih, D. J. H.; Martin, D. C. & Castelo-Branco, P. et al.​ (2013) 
    Journal of Clinical Oncology, 31(23) pp. 2927​-+​.​ DOI: https://doi.org/10.1200/JCO.2012.48.5052 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article | 
    ​ ​WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma​
    Zhukova, N.; Ramaswamy, V.; Remke, M.; Martin, D. C.; Castelo-Branco, P.; Zhang, C. H. & Fraser, M. et al.​ (2014) 
    Acta Neuropathologica Communications, 2(1) art. 174​.​ DOI: https://doi.org/10.1186/s40478-014-0174-y 
    ​Details  DOI  PMID  PMC 
  • 2014 | Journal Article | 
    ​ ​Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort​
    Pietsch, T.; Schmidt, R.; Remke, M.; Korshunov, A.; Hovestadt, V.; Jones, D. T. W. & Felsberg, J. et al.​ (2014) 
    Acta Neuropathologica, 128(1) pp. 137​-149​.​ DOI: https://doi.org/10.1007/s00401-014-1276-0 
    ​Details  DOI  PMID  PMC  WoS 
  • 2017 | Journal Article
    ​ ​Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response​
    Friedrich, C.; Shalaby, T.; Oehler, C.; Pruschy, M.; Seifert, B.; Picard, D. & Remke, M. et al.​ (2017) 
    Child's Nervous System, 33(9) pp. 1463​-1471​.​ DOI: https://doi.org/10.1007/s00381-017-3506-y 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100